Evidence map›Paper›PMID 25734869›Full record

ReviewCurrent opinion in anaesthesiology2015

Perioperatively acquired disorders of coagulation.

Oliver Grottke, Dietmar Fries, Bartolomeu Nascimento

Open access · hybridAbstract readReview
In one paragraph

Review in Current opinion in anaesthesiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Management of Coagulopathy in Bleeding Patients.Journal of clinical medicine · 2021
    Review
  7. Dynamic functional clot formation in patients undergoing endoscopic mucosal resection.JGH open : an open access journal of gastroenterology and hepatology · 2020
    Article
  8. Potential utility of new surgical hemostatic film using HydrofitJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Massive hemorrhage management-a best evidence topic report.Therapeutics and clinical risk management · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 4 countries.

Oliver GrottkeaDepartment of Anaesthesiology, RWTH Aachen University Hospital, Aachen, Germany bDepartment of Surgical and General Critical Care Medicine, Medical University Innsbruck, Innsbruck, Austria cDepartment of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Dietmar Fries
Bartolomeu Nascimento
GTx (United States) · USInnsbruck Medical University · ATUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo provide an overview of acquired coagulopathies that can occur in various perioperative clinical settings. Also described are coagulation disturbances linked to antithrombotic medications and currently available strategies to reverse their antithrombotic effects in situations of severe hemorrhage. RECENT

findingsRecent studies highlight the link between low fibrinogen and decreased fibrin polymerization in the development of acquired coagulopathy. Particularly, fibrin(ogen) deficits are observable after cardiopulmonary bypass in cardiac surgery, on arrival at the emergency room in trauma patients, and with ongoing bleeding after child birth. Regarding antithrombotic therapy, although new oral anticoagulants offer the possibility of efficacy and relative safety compared with vitamin K antagonists, reversal of their anticoagulant effect with nonspecific agents, including prothrombin complex concentrate, has provided conflicting results. Specific antidotes, currently being developed, are not yet licensed for clinical use, but initial results are promising. SUMMARY: Targeted hemostatic therapy aims to correct coagulopathies in specific clinical settings, and reduce the need for allogeneic transfusions, thus preventing massive transfusion and its deleterious outcomes. Although there are specific guidelines for reversing anticoagulation in patients treated with antiplatelet agents or warfarin, there is currently little evidence to advocate comprehensive recommendations to treat drug-induced coagulopathy associated with new oral anticoagulants.

Indexed as

Antifibrinolytic AgentsBlood Coagulation DisordersHumansIntraoperative ComplicationsPerioperative CarePostoperative ComplicationsAntifibrinolytic Agents

Identifiers

PMID25734869
PMCPMC4418784
OpenAlexW2004848451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.